Navigation Links
Genesis HealthCare Promotes Wendy LaBate To Senior Vice President of Operations for the Northeast Area
Date:2/4/2009

ANDOVER, Mass., Feb. 4 /PRNewswire/ -- Genesis HealthCare, a provider of long-term care services in New England for more than 25 years, announced today that Wendy LaBate has been promoted to Senior Vice President of Operations for the Northeast Area. In her new position, LaBate will be responsible for providing day-to-day oversight and support to all of Genesis' Regional Vice Presidents of Operations and Administrators in six states in order to support center operations, improve efficiencies and promote patient-centered care. In addition, LaBate represents Genesis and its services to local legislators, regulators and community associations throughout New England.

Ms. LaBate has been employed by Genesis HealthCare for more than fifteen years, most recently as Vice President of Clinical Operations for the Northeast Area. In that capacity, LaBate had oversight for the nursing care delivery systems and outcomes for all the Genesis skilled nursing and assisted living facilities in six New England states. In her prior work for Genesis, she has also served as an Administrator, Director of Nurses, and a Quality Improvement Coordinator at several Genesis centers in Massachusetts.

"We are thrilled to promote Wendy to the position of Senior Vice President of Operations," says Richard Blinn, President of Genesis HealthCare's Northeast Area. "Wendy is a seasoned healthcare executive, with more than 25 years experience in the healthcare industry. Her clinical expertise and leadership are strong assets to our Northeast Area and the entire Company."

Ms. LaBate earned both a Bachelor's degree and a Master's degree in nursing from the University of Phoenix. In addition, she holds a Master's in Healthcare Administration from the University of Massachusetts and a Bachelor's degree in Healthcare Administration from Rivier College. She has a Diploma in Nursing from Lowell General Hosp
'/>"/>

SOURCE Genesis HealthCare
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences
2. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2009 Results on February 4, 2009
3. Genesis Pharmaceuticals Appoints KPMG to Help Develop a SOX 404 Compliance Program
4. OmegaGenesis Announces Angiogenesis Application Collaboration
5. Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors
6. Tissue Genesis Applies CE Mark to Its Adult Stem Cell Isolation System
7. Cardiogenesis Reports Third Quarter 2008 Results
8. ThermoGenesis Presentation at Rodman & Renshaw Conference
9. Genesis Pharmaceuticals Launches New Corporate Website
10. ThermoGenesis Corp. to Announce First Quarter Fiscal 2009 Results on November 6, 2008
11. ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 Carahsoft and CDS Federal ... 23, 2014 at 2pm EST (11am PST), “Natural Language ... focuses on how technology can turn raw, heterogeneous data ... government agencies. The online webinar will last approximately one ...
(Date:1/14/2014)... EquitiesIQ, a leading informational research provider, has ... an emerging biomedical company acquiring, developing, manufacturing, and marketing ... Free report download: http://equitiesiq.com/reports/alliqua/ , In late ... and Board, which launched the company’s new strategy to ...
(Date:1/14/2014)... In recent years, growing suspicion about the ... development and promotion has led to unprecedented levels of ... concerns about the insidious impact of commercialization of research, ... to the world’s biggest pharmas for illegal marketing activities, ...
(Date:1/14/2014)... Cardiff, UK (PRWEB) January 13, 2014 ... leader with more than 20 years in the industry, ... and photonics . Hainsey will serve as the society’s ... have Dr. Hainsey join SPIE as our Technology Strategist, ...
Breaking Biology Technology:Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2
... TEL AVIV, Israel, BADAJOZ, Spain and SINGAPORE, August 5 ... been appointed as the,new Chief Executive Officer effective July ... 20 years of experience in sales,marketing and senior management ... VP of Marketing and Sales at UltraShape Ltd., a ...
... Lai-Goldman, Chief Medical Officer of LabCorp and Jack Ballantyne, ... ... Team, CARLSBAD, Calif., Aug. 5 GenVault Corporation ... Lai-Goldman and,Dr. Jack Ballantyne, have joined its Scientific Advisory ...
... - YM BioSciences Inc.,(AMEX: YMI , TSX: ... and commercializes differentiated products for patients worldwide,will hold ... Chairman and CEO, at,12:00pm EDT today, August 5, ... to discuss the preliminary results obtained from its,open-label, ...
Cached Biology Technology:Pollogen Announces Appointment of Ms. Yfat Scialom as Chief Executive Officer 2GenVault Expands Scientific Advisory Board 2GenVault Expands Scientific Advisory Board 3NOTICE OF YM BIOSCIENCES CONFERENCE CALL TO DISCUSS PHASE II DATA FOR NIMOTUZUMAB IN METASTATIC COLORECTAL CANCER 2
(Date:7/10/2014)... Foundation, a nonprofit organization funding cutting-edge, innovative research ... glaucoma and macular degeneration, today announced the recipients ... scientists in 19 U.S. states, the District of ... . , With these latest grants, BrightFocus ... research funding in 2014. , The research projects ...
(Date:7/10/2014)... ANN ARBOR Because the strong currents in the ... rupture of the oil pipeline beneath the channel would ... and Huron, according to a new University of Michigan ... one scenario examined in the study and accompanying animations, ... and Round Island after 12 hours and Bois Blanc ...
(Date:7/10/2014)... University Medical Center (CUMC) researchers have created a way ... pigmentosa (RP), a leading cause of vision loss. The ... induced pluripotent stem (iPS) cell technology to transform skin ... a patient-specific model for disease study and preclinical testing. ... Tsang, MD, PhD, showed that a form of RP ...
Breaking Biology News(10 mins):BrightFocus Foundation announces 55 new grantees in Alzheimer's and vision research 2BrightFocus Foundation announces 55 new grantees in Alzheimer's and vision research 3Straits of Mackinac 'worst possible place' for a Great Lakes oil spill 2Straits of Mackinac 'worst possible place' for a Great Lakes oil spill 3Patient-specific stem cells and personalized gene therapy 2Patient-specific stem cells and personalized gene therapy 3
... Functioning much like gears in a machine, cellular motor ... including muscle contraction, cell migration and cellular growth processes. ... of The Scripps Research Institute report that motor proteins ... long-term memories. The findings add an unexpected dimension to ...
... twin awards from the National Science Foundation (NSF) totaling ... Computational Sciences (NICS) will add 300 teraflops to the ... have access to more than 200 million additional service ... available from NICS to over 800 million and benefitting ...
... from the U.S., the researchers surrounding Prof. Dr. Martina Havenith ... a so-termed Rapid Communication in the prestigious American chemistry journal, ... The journal,s independent reviewers evaluated the work as one of ... household antifreeze Temperatures of minus 1.8 C ...
Cached Biology News:UCI-Scripps study links cellular motors to memory 2NICS to add more than 300 Teraflops to the NSF’s computing capacity 2Why fish don't freeze in the Arctic Ocean 2
Protein Marker Detection Pack contains biotinylate...
This antibody is specific for human J-chain as defined by ELISA assay using purified human immunoglobulin fragments as solid phase target antigen....
UltraMount is formulated for coverslipping sections stained with alcohol soluble chromogens, such as Fast-Red or AEC. No heating is required prior to use. Coverslips may be removed by soaking in wate...
This monoclonal antibody specifically recognizes Y. pestiscapsular F1 antigen. It does not cross-react with Y. pseudotuberculosisor Y. enterocolitica....
Biology Products: